JP2004533846A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533846A5
JP2004533846A5 JP2003512262A JP2003512262A JP2004533846A5 JP 2004533846 A5 JP2004533846 A5 JP 2004533846A5 JP 2003512262 A JP2003512262 A JP 2003512262A JP 2003512262 A JP2003512262 A JP 2003512262A JP 2004533846 A5 JP2004533846 A5 JP 2004533846A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
seq
substantially pure
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003512262A
Other languages
English (en)
Japanese (ja)
Other versions
JP4213581B2 (ja
JP2004533846A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2002/003203 external-priority patent/WO2003006492A2/en
Publication of JP2004533846A publication Critical patent/JP2004533846A/ja
Publication of JP2004533846A5 publication Critical patent/JP2004533846A5/ja
Application granted granted Critical
Publication of JP4213581B2 publication Critical patent/JP4213581B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003512262A 2001-07-13 2002-07-11 生物学的に活性なペプチド Expired - Fee Related JP4213581B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90449201A 2001-07-13 2001-07-13
PCT/GB2002/003203 WO2003006492A2 (en) 2001-07-13 2002-07-11 Biologically active peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007187713A Division JP2007312785A (ja) 2001-07-13 2007-07-19 生物学的に活性なペプチド

Publications (3)

Publication Number Publication Date
JP2004533846A JP2004533846A (ja) 2004-11-11
JP2004533846A5 true JP2004533846A5 (https=) 2008-06-26
JP4213581B2 JP4213581B2 (ja) 2009-01-21

Family

ID=25419251

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003512262A Expired - Fee Related JP4213581B2 (ja) 2001-07-13 2002-07-11 生物学的に活性なペプチド
JP2007187713A Pending JP2007312785A (ja) 2001-07-13 2007-07-19 生物学的に活性なペプチド
JP2008140488A Expired - Fee Related JP4316651B2 (ja) 2001-07-13 2008-05-29 生物学的に活性なペプチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007187713A Pending JP2007312785A (ja) 2001-07-13 2007-07-19 生物学的に活性なペプチド
JP2008140488A Expired - Fee Related JP4316651B2 (ja) 2001-07-13 2008-05-29 生物学的に活性なペプチド

Country Status (23)

Country Link
EP (3) EP1947109A3 (https=)
JP (3) JP4213581B2 (https=)
KR (2) KR100889992B1 (https=)
AT (2) ATE466871T1 (https=)
AU (1) AU2002319423B2 (https=)
BR (1) BR0210252A (https=)
CA (2) CA2707767C (https=)
DE (2) DE60236330D1 (https=)
DK (2) DK1478659T3 (https=)
ES (2) ES2316586T3 (https=)
IL (2) IL159827A0 (https=)
MX (1) MXPA03011190A (https=)
MY (1) MY138219A (https=)
NO (2) NO332061B1 (https=)
NZ (3) NZ529879A (https=)
PL (2) PL208666B1 (https=)
PT (2) PT1790655E (https=)
RU (2) RU2305107C2 (https=)
SA (1) SA04240478B1 (https=)
SG (2) SG142165A1 (https=)
UA (1) UA83989C2 (https=)
WO (1) WO2003006492A2 (https=)
ZA (2) ZA200401108B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1223602C (zh) 2001-07-13 2005-10-19 一泰医药研究(深圳)有限公司 序列号11的生物活性肽
WO2004055042A1 (en) * 2002-12-18 2004-07-01 Pepharm R & D Limited Biologically active peptide conjugates
TWI322815B (en) * 2003-06-26 2010-04-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide comprising tyrosyl-seryl-valine (ysv)
TWI353252B (en) * 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
CN1799623B (zh) * 2005-01-05 2011-01-26 康哲医药研究(深圳)有限公司 生物活性肽在制备用于防治关节炎的药物中的用途
NZ591825A (en) * 2005-07-26 2012-10-26 Cms Peptides Patent Holding Company Ltd Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
GB0918579D0 (en) * 2009-10-22 2009-12-09 Imp Innovations Ltd Gadd45beta targeting agents
RU2429005C1 (ru) * 2010-10-07 2011-09-20 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН Способ стимуляции противоопухолевой активности цитотоксических эффекторов иммунной системы
RU2615908C1 (ru) * 2016-05-16 2017-04-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ моделирования лимфогенного и гематогенного метастазирования мышиной меланомы В16 у белых нелинейных крыс
TWI890506B (zh) 2024-06-27 2025-07-11 開曼群島商味丹國際(控股)有限公司 具有抑制ace活性之胜肽及其組合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
WO1991009613A1 (en) * 1989-12-22 1991-07-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Synthetic peptides as modulators of functional responses of intact cells
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
EP1413585A3 (en) 1993-06-15 2004-08-04 E.I. Du Pont De Nemours And Company Novel, recombinantly produced spider silk analogs
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
JPH10503643A (ja) 1994-06-17 1998-04-07 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー 微生物中に遺伝物質を導入する方法およびその方法によってえられる形質転換体
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US5958416A (en) * 1994-12-16 1999-09-28 Regents Of The University Of Minnesota Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
AU719366B2 (en) 1995-10-24 2000-05-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Novel peptide
GB9606016D0 (en) * 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
DE69732378D1 (de) 1997-05-27 2005-03-03 Hanil Synthetic Fiber Co Ltd Verfahren zur herstellung von rekombinanten eiweissen durch verwendung von hocheffizienten expressionsvektoren aus saccharomyces cerevisiae
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
AU5585599A (en) * 1998-08-31 2000-03-21 University Of Washington Stable isotope metabolic labeling for analysis of biopolymers
US6413530B1 (en) * 1999-04-21 2002-07-02 University Of Florida Research Foundation, Inc. Pesticidal peptides
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
AU1197001A (en) * 1999-10-29 2001-05-14 Institute For Applied Biomedicine B cell clonal toxins and methods for using the same

Similar Documents

Publication Publication Date Title
KR100815408B1 (ko) 만성 간염용 치료 백신으로서의 안정화된 HBc 키메라입자
JP2004531242A5 (https=)
JP2002528060A5 (https=)
Kossovsky et al. Surface-modified nanocrystalline ceramics for drug delivery applications
JP2005511076A5 (https=)
JP2020528743A5 (https=)
US7309490B2 (en) Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
JPH01279842A (ja) A型及びb型肝炎混合アジュバントワクチン
JP2002542827A5 (https=)
RU2006105498A (ru) Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
JP2004533846A5 (https=)
JP2001518304A5 (https=)
JP2005102701A5 (https=)
CA2395499A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
CN1305490A (zh) 改良的用于制备胺与邻羟基醛的席夫碱加合物的方法以及基于该物质的组合物
JP2003509018A5 (https=)
JP2023529839A5 (https=)
CN114807153A (zh) 多种具有免疫刺激活性的CpG寡聚脱氧核苷酸及其应用
CN1405181A (zh) 血清白蛋白与干扰素的融合蛋白
CN1637013A (zh) 具有改善的免疫调节功能的经修饰的CpG寡聚脱氧核苷酸
JP2006502228A5 (https=)
CN101463089B (zh) 人血清白蛋白-干扰素融合蛋白及其编码基因与应用
RU2004104335A (ru) Биологически активные пептиды
JP2005512518A5 (https=)
JP2018533908A5 (https=)